This level of detail supports decision-making about deployment eligibility and retention while ensuring medical safety for the patient. Medical records must clearly document the diagnosis, rationale for TRT, monitoring schedule, and any adjustments to therapy. Adherence to dosing regimens, injection or transdermal application schedules, and documentation of side effects are essential components of ongoing care. Additionally, some branches impose specific restrictions on activities that could affect safety or performance, such as high-demand field duties or roles with limited medical support. Medical evaluators look for objective indicators—lab results, symptom control, side effects, and adherence to follow-up care—that help determine suitability for deployment. In some cases, a service member on TRT may be temporarily or permanently deemed non-deployable, depending on the stability of the condition and the stability of the treatment plan. Hormonal therapies can influence energy, focus, mood, and cardiovascular health, all of which bear on mission readiness.
Your doctor will measure your testosterone levels at the 3- and 6-month marks after treatment begins. Before starting TRT, your doctor should assess your risk for prostate cancer. If you've been diagnosed with an abnormally low T, testosterone replacement therapy (TRT) offers a lot of benefits. Data on the safety of TRT specific to our aging population is not currently available; however TRT has been linked to prostate cancer, BPH, polycythemia and OSA.
Once you start TRT, you’ll have regular appointments with your healthcare provider and routine blood tests. Your body will take some time to restart production of testosterone naturally. If you stop TRT, you’ll return to your normal level of testosterone.
To determine what’s a good testosterone level for your age, you also need to look at the clinical picture. You can optimize your hormones and feel good, McDevitt says. I gave you the hormones to become an adult and to reproduce’ and they start to slow down," says McDevitt. "Think about women going through menopause," says McDevitt. "After 35 years old, we see hormones start to drop," says McDevitt.
Any man who has a comorbidity that precludes TRT should be informed of all risks. The Baltimore Longitudinal Study of Aging reported the incidence of hypogonadism as 20% in men over 60 years of age, 30% in men over 70 years and 50% in men over 80 years of age. Testosterone has many beneficial effects, including increasing bone strength and density, inducing hematopoiesis, driving sexual function and libido, providing a cardioprotective effect and increasing muscle strength. Men on TRT should be monitored for side-effects such as polycythemia, peripheral edema, cardiac and hepatic dysfunction. The benefits seen with TRT, such as increased libido and energy level, beneficial effects on bone density, strength and muscle as well as cardioprotective effects, have been well-documented.

Gender: Female

Social links